Skip to main content
Country-Specific Sites

Interim Results of Rigicon Penile Prosthesis Implantation in a Single Center: The Largest Series in Türkiye

Author(s):
JOURNAL
Urology Research and Practice
YEAR
DOI
https://doi.org/10.5152/tud.2024.24122
View on Publisher Site

Abstract Short Summary

This retrospective study evaluated 250 Rigicon Infla10® penile implantations in Türkiye. With a 97.6% device survival rate over 3 years and 92.4% patient satisfaction, the results highlight the device's reliability and acceptance.

Abstract

Objective:

To evaluate interim outcomes, durability, and patient satisfaction after Rigicon Infla10® IPP implantation in a large single-center Turkish cohort.

Key Findings:

The revision/removal rate was low at 2.4%, with mechanical failure in only 1.2% of patients. No infections occurred. Device survival was 97.6% at 3 years. High satisfaction was reported by 92.4% of patients, demonstrating both clinical safety and acceptance.

Conclusion:

Rigicon Infla10® IPPs showed excellent durability and high patient satisfaction in the largest Turkish series. The findings support its effectiveness and reliability as a first-line surgical option for erectile dysfunction.

Clinical Relevance:

These results provide robust real-world evidence supporting the clinical use of Rigicon Infla10® as a safe and durable IPP, particularly relevant for patients with ED refractory to conservative treatments.

Keywords

Infla10 inflatable penile prosthesis erectile dysfunction patient satisfaction penile implant

This publication is available through the external link above. See the abstract for a summary of the research.

Back to Clinical Evidence